Celltrion Pharm Market Cap

Celltrion Pharm has a market cap or net worth of 2.14 trillion as of June 6, 2025. Its market cap has decreased by -47.80% in one year.

Market Cap

2.14T

Enterprise Value

n/a

Revenue

274.73B

Ranking

n/a

PE Ratio

82.85

Stock Price

49,300.00

Market Cap Chart

Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 2.14T, an increase of 3,130.73%. That is a compound annual growth rate of 19.68%.

Market Cap History

Date	Market Cap	% Change
Jun 5, 2025	2,144.28B	-13.06%
Dec 30, 2024	2,466.43B	-35.41%
Dec 28, 2023	3,818.49B	44.48%
Dec 29, 2022	2,642.93B	-43.45%
Dec 30, 2021	4,673.68B	-46.31%
Dec 30, 2020	8,705.45B	511.51%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.59T
Celltrion	34.68T
ALTEOGEN	20.36T
Yuhan	7,718.75B
SK Biopharmaceuticals	7,024.70B
HLB Co., Ltd.	6,741.95B
PharmaResearch	4,976.64B
LigaChem Biosciences	3,893.48B

Market Cap Rankings